Startups channel feed – Endpoints News

Startups channel feed

Metaphore Biotechnologies seeks to mimic nature with $50M for autoimmune, immunology drugs out of Flagship

3 years ago

Belgian biotech Dualyx enters Treg field with $44M for 2024 clinical entry

3 years ago

From 5AM's nest, neuroscience startup Nido Biosciences launches with $109M and PhI underway

3 years ago

New blood and cell therapy-focused venture fund emerges with $50M and a Jennifer Doudna spinout in tow

3 years ago

French biotech jumps into type 1 diabetes space with $30M Series A round

3 years ago

Gilead's M&A streak carries on with buyout of private PARP1, autoimmune biotech

3 years ago

CRISPR unicorn Mammoth backs off diagnostics research, laying off 35 on testing team to focus on therapeutics

3 years ago

Q&A: Acelyrin CEO Shao-Lee Lin details biotech's $540M IPO, finding 'diamonds in the rough'

3 years ago

Acelyrin's IPO is an 'N of 1', industry insiders say, as 50+ biotechs are still waiting for their moment on the markets

3 years ago

Reverse mergers say hey as biotechs trade low, hunt for alternatives and launch few IPOs

3 years ago

Cowen, Longwood add $735M to biopharma's pool of money

3 years ago

Magenta sets up Dianthus merger in quick, three-month about-face after ending trial due to patient death

3 years ago

ARTHEx nabs Series B for clinical trial of ASO in myotonic dystrophy as Vertex’s deals heat up the space

3 years ago

Durham startup raises Series A to tackle undruggable proteins, including cancer baddie Myc, with generative AI

3 years ago

'Undruggable is only at a given point in time': Prominent California scientists launch Initial Therapeutics with $75M

3 years ago

Acelyrin sets out for a 2021-sized IPO for California biotech’s PhIII drug

3 years ago

ROCK2 Part 2: Sam Waksal’s Graviton pairs up with Ovid Therapeutics in rare CNS indications

3 years ago

Sanofi's next chapter in Pompe: $150M for Maze pact as the biotech gears up in CKD

3 years ago

Seeker Biologics, a 5AM Ventures biotech led by ex-Translate Bio president, shuts down

3 years ago

Research startup Care Access lays off half of staff following Pfizer Lyme trial woes

3 years ago

Rhodium Scientific pursues manufacturing efforts in space

3 years ago

Exclusive: Therini raises $36M, will target fibrin protein for Alzheimer's and diabetic macular edema

3 years ago

Evommune raises $50M to fund clinical trials in skin diseases

3 years ago

Finch Therapeutics brings on new CEO, CFO after January layoffs and scrapping a PhIII trial

3 years ago

First page Previous page 29 30 313233 34 35 Next page Last page